{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:58:59Z","timestamp":1788296339125,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-023-02201-0","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T05:00:24Z","timestamp":1698901224000},"page":"333-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0230-8442","authenticated-orcid":false,"given":"\u00d6mer Furkan","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-2250","authenticated-orcid":false,"given":"Nur \u00d6zer","family":"\u015eensoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4363-0913","authenticated-orcid":false,"given":"Esra","family":"Akp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1996-5266","authenticated-orcid":false,"given":"G\u00fcnseli","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"2201_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fcvm.2018.00003","volume":"5","author":"MR de Vries","year":"2018","unstructured":"de Vries MR, Quax PHA (2018) Inflammation in vein graft disease. Front Cardiovasc Med 5:3","journal-title":"Front Cardiovasc Med"},{"issue":"02","key":"2201_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"F-J Neumann","year":"2019","unstructured":"Neumann F-J, Sousa-Uva M, Ahlsson A, ESC Scientific Document Group et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(02):87\u2013165","journal-title":"Eur Heart J"},{"issue":"08","key":"2201_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrcardio.2016.76","volume":"13","author":"MR de Vries","year":"2016","unstructured":"de Vries MR, Simons KH, Jukema JW, Braun J, Quax PH (2016) Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol 13(08):451\u2013470","journal-title":"Nat Rev Cardiol"},{"key":"2201_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/SLA.0b013e318288c38d","volume":"257","author":"RE Harskamp","year":"2013","unstructured":"Harskamp RE, Lopes RD, Baisden CE, de Win-ter RJ, Alexander JH (2013) Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg 257:824\u2013833","journal-title":"Ann Surg"},{"key":"2201_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jcin.2011.05.014","volume":"4","author":"MS Lee","year":"2011","unstructured":"Lee MS, Park SJ, Kandzari DE et al (2011) Saphenous vein graft intervention. JACC Cardiovasc Interv 4:831\u2013843","journal-title":"JACC Cardiovasc Interv"},{"key":"2201_CR6","first-page":"659","volume":"26","author":"J Soverow","year":"2014","unstructured":"Soverow J, Lee MS (2014) Saphenous vein graft intervention: status report 2014. J Invasive Cardiol 26:659\u2013667","journal-title":"J Invasive Cardiol"},{"key":"2201_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/187152512802651024","volume":"10","author":"P Salinas","year":"2012","unstructured":"Salinas P, Jimenez-Valero S, Moreno R et al (2012) Update in pharmacological management of coronary no-reflow phenomenon. Cardiovasc Hematol Agents Med Chem 10:256\u2013264","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"2201_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.33963\/KP.15603","volume":"78","author":"I\u0307 G\u00fcrbak","year":"2020","unstructured":"G\u00fcrbak I\u0307, Pan\u00e7 C, \u015eahin AA et al (2020) CHA2DS2-VASc score as a predictor of no-reflow phenomenon after saphenous vein graft percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes. Kardiol Pol 78:1129\u20131136","journal-title":"Kardiol Pol"},{"key":"2201_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(84)92447-4","volume":"1","author":"GA Oswald","year":"1984","unstructured":"Oswald GA, Corcoran S, Yudkin JS (1984) Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1:1264\u20131267","journal-title":"Lancet"},{"key":"2201_CR10","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.amjcard.2007.01.044","volume":"99","author":"M Ishihara","year":"2007","unstructured":"Ishihara M, Kagawa E, Inoue I et al (2007) Impact of admission hyperglycemia and diabetes mellitus on short and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 99:1674\u20131679","journal-title":"Am J Cardiol"},{"key":"2201_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/CIRCIMAGING.112.974998","volume":"5","author":"I Eitel","year":"2012","unstructured":"Eitel I, Hintze S, de Waha S et al (2012) Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging. Circ Cardiovasc Imaging 5:708\u2013718","journal-title":"Circ Cardiovasc Imaging"},{"key":"2201_CR12","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.ijcard.2012.06.054","volume":"167","author":"D Planer","year":"2013","unstructured":"Planer D, Witzenbichler B, Guagliumi G et al (2013) Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial. Int J Cardiol 167:2572\u20132579","journal-title":"Int J Cardiol"},{"key":"2201_CR13","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1210\/jc.2015-2660","volume":"100","author":"GW Roberts","year":"2015","unstructured":"Roberts GW, Quinn SJ, Valentine N et al (2015) Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab 100:4490\u20134497","journal-title":"J Clin Endocrinol Metab"},{"key":"2201_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2337\/dc17-1732","volume":"41","author":"G Marenzi","year":"2018","unstructured":"Marenzi G, Cosentino N, Milazzo V et al (2018) Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study. Diabetes Care 41:847\u2013853","journal-title":"Diabetes Care"},{"key":"2201_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0003319719875632","volume":"71","author":"S Gao","year":"2020","unstructured":"Gao S, Liu Q, Ding X et al (2020) Predictive value of the acute-to-chronic glycemic ratio for in-hospital outcomes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Angiology 71:38\u201347","journal-title":"Angiology"},{"key":"2201_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.pcad.2007.11.004","volume":"50","author":"G De Luca","year":"2008","unstructured":"De Luca G, Suryapranata H, Marino P (2008) Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status. Prog Cardiovasc Dis 50:352\u2013382. https:\/\/doi.org\/10.1016\/j.pcad.2007.11.004","journal-title":"Prog Cardiovasc Dis"},{"key":"2201_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ihj.2016.04.006","volume":"68","author":"S Gupta","year":"2016","unstructured":"Gupta S, Gupta MM (2016) No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J 68:539\u2013551. https:\/\/doi.org\/10.1016\/j.ihj.2016.04.006","journal-title":"Indian Heart J"},{"key":"2201_CR18","first-page":"4S","volume":"21","author":"RA Montone","year":"2020","unstructured":"Montone RA, Camilli M, Del Buono MG et al (2020) \u201cNo-reflow\u201d: update su diagnosi, fisiopatologia e strategie terapeutiche. G Ital Cardiol 21:4S-14S","journal-title":"G Ital Cardiol"},{"key":"2201_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"2201_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1253\/circj.72.716","volume":"72","author":"C Kirma","year":"2008","unstructured":"Kirma C, Izgi A, Dundar C et al (2008) Clinical and prodedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J 72:716\u2013721. https:\/\/doi.org\/10.1253\/circj.72.716","journal-title":"Circ J"},{"key":"2201_CR21","first-page":"6B","volume":"22","author":"G Sianos","year":"2010","unstructured":"Sianos G, Papafaklis MI, Serruys PW (2010) Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 22:6B-14B","journal-title":"J Invasive Cardiol"},{"key":"2201_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS et al (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J 40:237\u2013269","journal-title":"Eur Heart J"},{"key":"2201_CR23","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association (2018) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care 41:S13\u2013S27","journal-title":"Diabetes Care"},{"key":"2201_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ahj.2009.10.004","volume":"158","author":"B Cid \u00c1lvarez","year":"2009","unstructured":"Cid \u00c1lvarez B, Gude F, Cadarso Su\u00e1rez C et al (2009) Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: Nonlinearity of hazard ratios and time dependent comparison. Am Heart J 158:989\u2013997. https:\/\/doi.org\/10.1016\/j.ahj.2009.10.004","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"2201_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dom.15013","volume":"25","author":"X Li","year":"2023","unstructured":"Li X, Hou X, Zhang H et al (2023) Association between stress hyperglycaemia and in-hospital cardiac events after coronary artery bypass grafting in patients without diabetes: a retrospective observational study of 5450 patients. Diabetes Obes Metab 25(Suppl 1):34\u201342. https:\/\/doi.org\/10.1111\/dom.15013","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2201_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabet.2016.07.036","volume":"43","author":"YW Su","year":"2017","unstructured":"Su YW, Hsu CY, Guo YW, Chen HS (2017) Usefulness of the plasma glucose concentration-to-HbA(1c) ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab 43(1):40\u201347. https:\/\/doi.org\/10.1016\/j.diabet.2016.07.036","journal-title":"Diabetes Metab"},{"key":"2201_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijcard.2017.02.065","volume":"241","author":"Y Yang","year":"2017","unstructured":"Yang Y, Kim TH, Yoon KH et al (2017) The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention. Int J Cardiol 241:57\u201363. https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.065","journal-title":"Int J Cardiol"},{"key":"2201_CR28","first-page":"3","volume":"80","author":"G Eid-Lidt","year":"2010","unstructured":"Eid-Lidt G, Gaspar J, Adames AE et al (2010) Long-term outcomes of saphenous vein graft stenting compared with native coronary artery stenting in patients with previous coronary artery bypass graft surgery. Arch Cardiol Mex 80:3\u20139","journal-title":"Arch Cardiol Mex"},{"key":"2201_CR29","first-page":"221","volume":"13","author":"M Hashemi-Jazi","year":"2017","unstructured":"Hashemi-Jazi M, Hosseini SM, Gholamrezaei A (2017) Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts. ARYA Atheroscler 13:221\u2013229","journal-title":"ARYA Atheroscler"},{"key":"2201_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.amjcard.2010.10.071","volume":"107","author":"A Erkol","year":"2011","unstructured":"Erkol A, Pala S, K\u0131rma C et al (2011) Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. Am J Cardiol 107:857\u2013862","journal-title":"Am J Cardiol"},{"issue":"1","key":"2201_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.atherosclerosis.2011.12.031","volume":"221","author":"A Erkol","year":"2012","unstructured":"Erkol A, Oduncu V, Pala S et al (2012) Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. Atherosclerosis 221(1):254\u2013259. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.12.031. (Epub 2011 Dec 27 PMID: 22265272)","journal-title":"Atherosclerosis"},{"issue":"4","key":"2201_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0040-1714751","volume":"29","author":"T Cankurt","year":"2020","unstructured":"Cankurt T, Celik \u0130E, Ozturk S, Maden O (2020) Inflammatory conditions in acute coronary syndrome patients treated with percutaneous coronary intervention of saphenous vein graft. Int J Angiol 29(4):237\u2013244. https:\/\/doi.org\/10.1055\/s-0040-1714751. (Epub 2020 Aug 30. PMID: 33268974; PMCID: PMC7690989)","journal-title":"Int J Angiol"},{"issue":"14","key":"2201_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"Jean-Philippe Collet and others","year":"2021","unstructured":"Jean-Philippe Collet and others (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 42(14):1289\u20131367. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575","journal-title":"Eur Heart J"},{"issue":"6","key":"2201_CR34","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.26355\/eurrev_202303_31774","volume":"27","author":"Y \u00d6zen","year":"2023","unstructured":"\u00d6zen Y, Bilal \u00d6M (2023) Assessment of systemic immune-inflammation index as an independent surrogate biomarker of no-reflow phenomenon in acute coronary syndrome patients with coronary artery bypass grafting undergoing percutaneous coronary intervention of saphenous vein graft. Eur Rev Med Pharmacol Sci 27(6):2394\u20132403. https:\/\/doi.org\/10.26355\/eurrev_202303_31774. (PMID: 37013758)","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"2201_CR35","first-page":"221","volume":"13","author":"M Hashemi-Jazi","year":"2017","unstructured":"Hashemi-Jazi M, Hosseini SM, Gholamrezaei A (2017) Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts. ARYA Atheroscler 13(5):221\u2013229","journal-title":"ARYA Atheroscler"},{"issue":"3","key":"2201_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-8703(03)00309-0","volume":"146","author":"L Leborgne","year":"2003","unstructured":"Leborgne L, Cheneau E, Pichard A et al (2003) Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J 146(3):501\u2013506. https:\/\/doi.org\/10.1016\/S0002-8703(03)00309-0","journal-title":"Am Heart J"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-023-02201-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-023-02201-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-023-02201-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T06:15:45Z","timestamp":1710828945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-023-02201-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1007\/s00592-023-02201-0","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no known competing financial interests or personal relationships that may appear to affect the work reported in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures in this study including human participants were applied in compliance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and subsequent revisions or comparable ethical standards. No animals were used in this study. Approval for the study was granted by the Local Ethics Committee (SB\u00dc Bursa Higher Specialization Training and Research Hospital Clinical Research Ethics Committee, no. 2011-KAEK-25 2023\/02-09).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of retrospective study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}